DealForma Research

Recent Articles

Global Healthcare and Life Sciences Venture Funding – 2025 Review

February 6, 2026

Global Healthcare and Life Sciences M&A – 2025 Review

February 2, 2026

Global Healthcare and Life Sciences R&D Partnerships – 2025 Review

January 26, 2026

Global Healthcare and Life Sciences – 2025 Review

January 21, 2026

AI-ML Drug Discovery and Licensing R&D, M&A, Ventures and IPOs – 2025 Review

January 13, 2026

Infectious R&D Partnerships, M&A and Venture Funding – Q3 2025 Review

January 13, 2026

Endocrine-Metabolic R&D Partnerships, M&A and Venture Funding – Q3 2025 Review

January 3, 2026

Neurology R&D Partnerships, M&A and Venture Funding – Q3 2025 Review

December 16, 2025

Gene Therapy & Vectors R&D Partnerships and Venture Funding – Q3 2025 Review

December 13, 2025

Cardiovascular R&D Partnerships, M&A and Venture Funding by Tech – Q3 2025 Review

December 8, 2025

Cardiovascular R&D Partnerships, M&A and Venture Funding – Q3 2025 Review

December 3, 2025

Cancer R&D Partnerships, M&A and Venture Funding by Tech – Q3 2025 Review

November 24, 2025

Cancer R&D Partnerships, M&A and Venture Funding – 2024 to Q3 2025 Review

November 17, 2025

All of this by stage, disease indication, modality, target…

+ 0 k

Licensing Deals

+ 0 k

M&A

+ 0 k

Other Deals

+ 0 k

Funding Rounds

+ 0 k

Company Profiles

+ 0 k

Drug Sales Figures